New study aims to prioritize the patient recovery experience when determining anesthetic options

Researchers from University of Michigan and Washington University in St. Louis receive $33 million in funding to lead a study comparing anesthetic medications

Author | Kelly Malcom

More than 50,000 surgical patients receive anesthetic care in the U.S. each day. But when it comes to deciding between two anesthetic medications that have been in use for decades, clinicians and patients have little scientific evidence to compare effectiveness and risks.

A new study led by University of Michigan and Washington University in St. Louis aims to compare intravenous propofol anesthesia with inhaled potent volatile anesthesia to determine which technique offers a better patient recovery experience and clinical outcomes.

The Patient-Centered Outcomes Research Institute (PCORI) has awarded nearly $33 million in funding to support THRIVE — Trajectories of Recovery After Intravenous Propofol vs Inhaled Volatile Anesthesia. This 6.5-year study will be conducted by the Multicenter Perioperative Outcomes Group (MPOG), for which U-M is the coordinating center. MPOG members U-M, Washington University, University of Pennsylvania, and Stanford University will lead the design and planning of the study with additional MPOG centers enrolling patients.

U-M’s Sachin Kheterpal, M.D., MBA, and Washington University’s Michael Avidan, MBBCh, are the study’s co-principal investigators.

“We see variation in patient experience on a daily basis — recovery from surgery and anesthesia can range from a few hours to months. This study is focused on helping patients recover as quickly as possible so that they can get back to their daily routines,” said Kheterpal, a Professor of Anesthesiology and MPOG Research Director. “We are thrilled to receive support from PCORI as we embark on this large-scale study, as we believe this work has the potential to rapidly inform and improve perioperative patient care.”

Both intravenous propofol and inhaled volatile anesthetics have been in use for decades, have established safety and efficacy, and are used thousands of times daily in operating rooms  across the country. In this study, researchers will compare the quality of recovery in the days after surgery as well as the incidence of the devastating and rare complication of unintended intraoperative awareness with recall.

“General anesthesia is widely regarded as one of the most important medical advances, allowing millions of people to safely undergo invasive procedures without suffering,” said Avidan, the Dr. Seymour and Rose T Brown Professor of Anesthesiology and Head of the Department of Anesthesiology at Washington University. “The THRIVE trial will answer the fundamental question regarding which of the two main anesthetic techniques provides a superior patient experience during the recovery period, without compromising safety.”

The 12,500-patient trial will include adult patients undergoing scheduled, non-cardiac surgery. Eligible patients will be approached prior to surgery and invited to participate. After consenting to the study, patients will be randomized to one of the two study medications. A subset of patients will be provided a fitness tracker or smartwatch days to weeks before surgery to understand their baseline activity, heart rate, sleep patterns, and other wearable signals. All patients will be provided a smartphone app (or website link) to help with collection of patient reported outcomes. Study personnel will follow up with the patients for up to 90 days to understand changes in recovery, delirium, functional status, and other outcomes important to patients and clinicians alike.

Twelve MPOG member institutions will serve as clinical sites, representing varying geographic locations, as well as a mix of academic and private institutions. Researchers expect to launch a 200-patient pilot program within the year, with the full trial to follow.

“MPOG, with its existing set of collaborators, data collection infrastructure, and engagement with clinicians at the point of care, was designed for projects like THRIVE,” Kheterpal said. “We connect with more than 5,000 anesthesia clinicians every month, including attendings, residents, nurse anesthetists and anesthesia assistants. That’s the type of teamwork and national reach that it takes to answer important questions like this.”

Funding for the study has been approved pending completion of a business and programmatic review by PCORI staff and issuance of a formal award contract. PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed healthcare decisions. For more information about PCORI’s funding, visitwww.pcori.org.

###

Michigan Medicine is one of the nation's leading academic medical centers, with three hospitals, one of the 10 largest biomedical research budgets, and national-level strength in a broad range of specialties. It includes the University Hospital, C.S. Mott Children's Hospital, Von Voigtlander Women's Hospital, the U-M Medical School and its Faculty Group Practice, and specialty centers in cancer, cardiovascular disease, depression, diabetes, eye conditions, geriatrics, health policy, neurosciences and organ transplant. Michigan Medicine is part of the University of Michigan, and has a close affiliation with the VA Ann Arbor Healthcare System.

Washington University School of Medicine's 1,700 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's hospitals. The School of Medicine is a leader in medical research, teaching and patient care, consistently ranking among the top medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's hospitals, the School of Medicine is linked to BJC HealthCare.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Illustration of three older women playing cards at a table
Health Lab
Research needed on support for nontraditional caregivers providing care for people with Alzheimer’s disease and related dementias
A growing number of people living with Alzheimer’s disease and related dementias – especially those from diverse backgrounds – receive care from a network of individuals that increasingly includes nontraditional informal caregivers.
Aerial view of University of Michigan Health hospital in Ann Arbor, Michigan.
News Release
University of Michigan Health purchases land in Troy for new clinical facility
University of Michigan Health will purchase 7.28 acres of vacant land at the former Kmart headquarters location. U-M Health plans to build a multi-specialty facility on the property to expand specialty clinical services and increase patient access to the Oakland County region
Headshot of Shahzad Mian, M.D.
News Release
Michigan Medicine names new chair of Department of Ophthalmology and Visual Sciences
Shahzad I. Mian, M.D., has been appointed chair of the Department of Ophthalmology and Visual Sciences and the F. Bruce Fralick Professor of Ophthalmology in the Medical School and the Director of the W.K. Kellogg Eye Center
George Mashour, M.D., Ph.D. standing in front of a bookcase, smiling. He is wearing a dark suit, white shirt, dark striped tie and dark framed glasses.
News Release
George Mashour, M.D., Ph.D. appointed senior associate dean for faculty and faculty development
George A. Mashour, M.D., Ph.D., has been appointed senior associate dean for faculty and faculty development of the University of Michigan Medical School by the U-M Board of Regents, effective May 1, 2024.
c.s_mott_childrens_hospital
News Release
$5.4M pediatric emergency services fast track clinic to serve lower acuity cases
University of Michigan Health C.S. Mott Children’s Hospital plans to build a $5.4 million emergency services fast track clinic to treat children, teens and young adults with lower acuity conditions.
Close up image of red blood cells moving through veins
Health Lab
Discovery reveals how this common stinky gas is processed to promote blood vessel growth
A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.